UBE2D3 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL18180873	0.41	3/20
SCHEMBL20642960	0.69	2/20
SCHEMBL22010115	0.69	2/20
SCHEMBL22155112	0.69	2/20
SCHEMBL20642979	0.67	2/20
SCHEMBL20642955	0.60	2/20
SCHEMBL21951130	0.60	2/20
SCHEMBL18334098	0.43	2/20
SCHEMBL30834932	0.41	2/20
SCHEMBL17147746	0.41	2/20
SCHEMBL17147754	0.41	2/20
SCHEMBL15941718	0.40	2/20
SCHEMBL17301653	0.40	2/20
SCHEMBL17147750	0.37	2/20
SCHEMBL29935069	0.36	2/20
SCHEMBL31395402	0.33	2/20
SCHEMBL27930878	0.32	2/20
SCHEMBL29627140	0.32	2/20
SCHEMBL16283684	0.32	2/20
SCHEMBL20642994	1.00	1/20

Clinical trials — most relevant to UBE2D3 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Is Vitamin D2 Treatment-associated Decrease in 25(OH)D3 Level a Reciprocal Phenomena?	PHASE4	COMPLETED
Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis	PHASE2/PHASE3	UNKNOWN
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer	PHASE3	COMPLETED
The Effect of Calcium and Vitamin D Supplements on Metabolic and Hormonal Disturbances in Polycystic Ovary Syndrome Patients	PHASE3	COMPLETED
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy	PHASE2	ACTIVE_NOT_RECRUITING
Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)	PHASE2	COMPLETED
A Open-label Study of Ultra-High Dose Dexamethasone for Relapsed Multiple Myeloma	PHASE2	WITHDRAWN
Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes	PHASE2	UNKNOWN
IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer	PHASE2	UNKNOWN
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck	PHASE1	COMPLETED
Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome	nan	COMPLETED
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis	nan	UNKNOWN
Evaluating Response to Vitamin D3 and K2 Supplementation in Healthcare Personnel	nan	RECRUITING
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors	nan	NOT_YET_RECRUITING
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin	nan	UNKNOWN
Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases	nan	UNKNOWN
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma	nan	COMPLETED
A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS	nan	RECRUITING
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature.	nan	UNKNOWN
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk	nan	NOT_YET_RECRUITING
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages	nan	COMPLETED
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)	nan	UNKNOWN
Endocrine Disruptors and Life STILe in Breast Cancer Development	nan	UNKNOWN
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2	nan	UNKNOWN
ADAPT: Efficacy of a Dietary Supplement During and After Exercise	nan	COMPLETED
Is There Association Between Vitamin D Levels And Insulin Resistance In Polycystic Ovary Syndrome?	nan	UNKNOWN
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas	nan	ACTIVE_NOT_RECRUITING
Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies	nan	ENROLLING_BY_INVITATION
VITamin D and OmegA-3 TriaL: Effects on Mammographic Density and Breast Tissue	nan	UNKNOWN
Prognostic Value of Vitamin D Levels in Egyptian Females With Breast Cancer	nan	UNKNOWN

Related proteins — ESM-2 sequence neighbours (a UBE2D3 binder may also engage these)

Protein	Name	Similarity
Q5R4V7	—	1.000	Q5R4V7 →
Q06AA9	—	1.000	Q06AA9 →
Q4R5N4	—	1.000	Q4R5N4 →
P61078	—	1.000	P61078 →
P61079	—	1.000	P61079 →
Q3ZCF7	—	1.000	Q3ZCF7 →
P62840	—	1.000	P62840 →
P62837	—	1.000	P62837 →
P25867	—	1.000	P25867 →
P61080	—	1.000	P61080 →
P62838	—	1.000	P62838 →
Q1RMX2	—	1.000	Q1RMX2 →
P62839	—	1.000	P62839 →
Q9UVR2	—	1.000	Q9UVR2 →
Q8S920	—	1.000	Q8S920 →
P70711	—	1.000	P70711 →
P35129	—	1.000	P35129 →
P51668	—	1.000	P51668 →
D3ZDK2	—	1.000	D3ZDK2 →
Q9Y2X8	—	1.000	Q9Y2X8 →
P43102	—	1.000	P43102 →
A5PKP9	—	1.000	A5PKP9 →
Q2TA10	—	0.999	Q2TA10 →
P35135	—	0.999	P35135 →
P35132	—	0.999	P35132 →
Q6ZWY6	—	0.999	Q6ZWY6 →
Q9C9Y7	—	0.999	Q9C9Y7 →
P35131	—	0.998	P35131 →
P35133	—	0.998	P35133 →
O74196	—	0.997	O74196 →